The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?

World Journal of Clinical Oncology ◽

10.5306/wjco.v6.i4.45 ◽

2015 ◽

Vol 6 (4) ◽

pp. 45 ◽

Cited By ~ 4

Author(s):

Edurne Arriola ◽

Álvaro Taus ◽

David Casadevall

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽

Study of the Safety and Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in 97 Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33922-3 ◽

2012 ◽

Vol 23 ◽

pp. ix433

Author(s):

M. Ishibashi ◽

K. Ogawa ◽

S. Motizuki ◽

S. Hanada ◽

H. Uruga ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2016.01.003 ◽

2016 ◽

Vol 93 ◽

pp. 59-68 ◽

Cited By ~ 71

Author(s):

Chee-Seng Tan ◽

Byoung-Chul Cho ◽

Ross A. Soo

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors

Lung Cancer ◽

10.1016/j.lungcan.2019.04.003 ◽

2019 ◽

Vol 132 ◽

pp. 45-53 ◽

Cited By ~ 2

Author(s):

Shaohua Cui ◽

Yiqian Ni ◽

Yizhuo Zhao ◽

Zonghai Li ◽

Liwen Xiong ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Circulating Tumor Cell ◽

Small Cell ◽

Small Cell Lung ◽

Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318227e8c6 ◽

2011 ◽

Vol 6 (11) ◽

pp. 1895-1901 ◽

Cited By ~ 72

Author(s):

Tommaso De Pas ◽

Francesca Toffalorio ◽

Michela Manzotti ◽

Caterina Fumagalli ◽

Gianluca Spitaleri ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis

Translational Lung Cancer Research ◽

10.21037/tlcr.2017.10.03 ◽

2017 ◽

Vol 6 (S1) ◽

pp. S21-S34 ◽

Cited By ~ 8

Author(s):

José Luís González-Larriba ◽

Martín Lázaro-Quintela ◽

Manuel Cobo ◽

Manuel Dómine ◽

Margarita Majem ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2013.05.001 ◽

2013 ◽

Vol 39 (8) ◽

pp. 839-850 ◽

Cited By ~ 66

Author(s):

Monic Roengvoraphoj ◽

Gregory J. Tsongalis ◽

Konstantin H. Dragnev ◽

James R. Rigas

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Initial Therapy ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA ◽

10.1001/jama.2014.3314 ◽

2014 ◽

Vol 311 (14) ◽

pp. 1430 ◽

Cited By ~ 93

Author(s):

June-Koo Lee ◽

Seokyung Hahn ◽

Dong-Wan Kim ◽

Koung Jin Suh ◽

Bhumsuk Keam ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Wild Type ◽

Small Cell Lung ◽

Conventional Chemotherapy ◽

Real world prospective data on tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor mutation positive non-small cell lung cancer at the Edinburgh Cancer Centre

Lung Cancer ◽

10.1016/s0169-5002(21)00278-6 ◽

2021 ◽

Vol 156 ◽

pp. S32

Author(s):

Amanda Swan ◽

Zhuang Boh ◽

Ailsa Patrizio ◽

Iain Phillips ◽

Tamasin Evans ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Data ◽

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells

Translational Cancer Research ◽

10.21037/tcr-20-1441 ◽

2020 ◽

Vol 9 (9) ◽

pp. 5473-5483

Author(s):

Amin Li ◽

Weiya Cao ◽

Xueke Liu ◽

Yinci Zhang ◽

Yongfang Ma ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Growth Factor Receptor ◽

Small Cell ◽

Wild Type ◽

Small Cell Lung ◽